Trump Nominates Scott Gottlieb, MD, to Head FDA
|
WH
Toni Clarke reporting for
Reuters on
3.10.17:
U.S. President
Donald Trump has chosen
Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the U.S.
Food and Drug Administration, the
White House said on Friday.
WIM
According to the article:
If confirmed by the
Senate, Gottlieb would be in charge of implementing Trump's plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco.
Gottlieb is well known on
Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favorably by drug companies and pharmaceutical investors. He sits on the boards of several small drug and biotech companies and is an adviser to
GlaxoSmithKline Plc.
|
|
CMS pick Seema Verma gets one step closer to confirmation
|
WH
The
Senate agreed on Thursday to end the debate over the nomination of
Seema Verma as the head of the
Centers for Medicare & Medicaid Services and set up a final confirmation vote that will likely take place early next week.
WIM
According to Ms. MacDonald:
The 54-44 vote once again fell mostly across party lines, with 43 Democrats voting against ending the discussion.
Bernie Sanders, I-Vt., also voted nay. Two Senators,
Johnny Isakson, R-Ga., and
Marco Rubio, R-Fla., did not vote.
Despite opposition from Democrats, it is likely she will be confirmed next week.
Verma is the president, CEO and founder of
SVC Inc., a national health policy consulting company. She has close ties to Vice President
Mike Pence, with whom she worked on Indiana's
Medicaid expansion plan when he was governor.
|
|
|
WH
In the March edition of
SFHN,
Vanessa Orr interviews
Matt Gracey, CEO of
Danna-Gracey headquartered in Delray Beach.
"We are expecting the market to become more difficult for doctors as we transition from the soft market conditions that we have now to a harder market as a result of the increase in frequency of claims against Florida doctors, and the severity of judgments against doctors in Florida - both are increasing," according to Mr. Gracey.
WIM
"We're warning doctors to place their malpractice insurance with a well-valued, financially secure company because small and unnoted insurers will have even more trouble because they are only able to compete on pricing," said Gracey. "Their claims handling is also not as good as that of rated carriers - they are forced to settle claims that a bigger company would be defending."
|
|
Healthcare CEOs concerned about cyber threats but few are taking action
|
WH
In
March 6, 2017
press release,
PwC reveals their latest survey results:
PwC's
20th Annual Global CEO Survey looked at the perspectives of 1,379 CEOs, which included responses from 56 healthcare leaders in 27 countries. The sector summary,
'A new treatment?: Healthcare findings from the 20th Annual Global CEO Survey' canvassed views from industry respondents about where we are now, what the future may hold and what business can do to make a positive difference.
WIM
The survey found that Most healthcare CEOs believe it's harder for businesses to gain and keep trust in the digital world, citing cyber threats as a growing concern and breaches in data security and ethics as the number one risk to stakeholders' trust. While most healthcare CEOs are taking action now on data security and ethics, few are taking action on cyber security activity.
|
|
About Us |
Florida Health Industry Week in Review is published every Monday by
FHIcommunications.
Each Monday morning we share the top healthcare headlines of the previous week and summarize
What Happened (WH) and
Why It Matters (WIM).
To learn how you can join our team of editorial contributors, contact
Jeffrey Herschler
.
|
FHIcommunications
|
Publisher of...
Week in Review,
Specialty Focus,
Updates in Pediatrics, FHIweekly &
Game Changers
~~~~~~~~~
|
Inside FloridaHealthIndustry.com
|
|
INFORM | CONNECT | ENGAGE
|
|
|
|